Laying off up to 17 employees.
All entries for: Rare Disease
February 3, 2025
Omega Therapeutics
Layoffs
Cambridge, MA
51-200 employees
Drug Type: Biologic, Small Molecule
February 3, 2025
Viracta Therapeutics
Layoffs
Cardiff, CA
1-50 employees
Company closed and laid off all staff.
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
January 28, 2025
I-Mab
Layoffs
Rockville, MD
201-500 employees
27% reduction in workforce.
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
January 27, 2025
Allakos
Layoffs
51-200 employees
75% reduction in workforce.
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
January 22, 2025
Biogen
Layoffs
Cambridge, MA
5,001-10,000 employees
Laying off an undisclosed number of employees.
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
January 20, 2025
Daiichi Sankyo
Discontinued Research
Basking Ridge, NJ
10,001-50,000 employees
A study on the efficacy of DS-2325a for patients with Netherton Syndrome was terminated based on a business decision by the sponsor.
1 Discontinued Research Program
Disease Area: Rare Diseases
Drug Type: Biologic
January 13, 2025
Apellis
Layoffs
Waltham, MA
501-1,000 employees
Laying off about 40 non-U.S. employees.
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
January 10, 2025
Y-mAbs Therapeutics
Layoffs
New York, NY
51-200 employees
Y-mAbs anticipates a reduction in its current workforce of up to approximately 13%.
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
January 10, 2025
Passage Bio
Layoffs
Philadelphia, PA
51-200 employees
This transition, coupled with an associated reduction in workforce of approximately 55% and reductions in operating expenses, is expected to extend cash runway into the first quarter of 2027.
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
January 9, 2025
IGM Biosciences
Layoffs
Mountain View, CA
201-500 employees
Company is immediately taking steps, including an approximately 73% reduction in workforce, to preserve cash.
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
